Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor.
Nishimura
T
T
Department of Immunology, Tokai University School of Medicine, Isehara, Japan.
Watanabe
K
K
Lee
U
U
Yahata
T
T
Ando
K
K
Kimura
M
M
Hiroyama
Y
Y
Kobayashi
M
M
Herrmann
S H
SH
Habu
S
S
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006131:Growth Inhibitors / Q000627:therapeutic use; D018664:Interleukin-12 / Q000627:therapeutic use*; D008223:Lymphoma / Q000276:immunology / Q000473:pathology / Q000628:therapy; D008546:Melanoma, Experimental / Q000276:immunology / Q000473:pathology / Q000628:therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009368:Neoplasm Transplantation; D010212:Papilloma / Q000139:chemically induced / Q000628:therapy; D013274:Stomach Neoplasms / Q000139:chemically induced / Q000628:therapy
D000970:Antineoplastic Agents; D006131:Growth Inhibitors; D018664:Interleukin-12